Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Ndsri Progress Reports topic

No spam. Unsubscribe anytime.

FDA reviewing NDSRI progress reports submitted August 1; no firm public update date

U.S. Food and Drug Administration (FDA) panel · July 30, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

FDA staff said the agency received the NDSRI progress reports on 08/01/2025 and is compiling and reviewing them; staff said they hope to issue a public announcement about next steps but have no specific date yet.

An attendee asked whether FDA could provide a timeline for feedback on NDSRI progress reports that were due 08/01/2025. An agency official said the agency requested the reports on that date, is reviewing them and compiling the information, and hopes to make a public announcement about next steps once analysis is complete.

"We did request that people provide the progress reports on 08/01/2025...we are looking at all those progress reports. I can guarantee you that. But...we're gonna compile it...and then based upon that, we will hopefully make it a public announcement based upon the next steps," the official said, adding there is no tentative date yet for public feedback.